President/CEO
Immunoglobulin National Society
Luba Sobolevsky, PharmD, IgCP® is the President/CEO of Immunoglobulin National Society, the central healthcare organization in the field of Ig therapy and biologics. In her executive role at IgNS, Dr. Sobolevsky oversees the advancement of clinical standards, resources, education, certification, accreditation, patient advocacy and alliances. Dr. Sobolevsky holds a Pharm.D. degree from the University of Southern California, and a B.A. from the University of California, Los Angeles. Dr. Sobolevsky’s career has included a variety of leadership roles across the healthcare field, including clinical, education, and pharmaceutical industry. She has been actively engaged in research and publication in the areas of optimizing the immunoglobulin practice and patient experience, health equity, healthcare team competencies, and improvement in screening and diagnosis of rare diseases.